(Q35000906)

5 August 2017

1 reference

title

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

7

Rafael Rosell

1 reference

5 August 2017

6

Giorgio Scagliotti

1 reference

5 August 2017

Carme Sarries

1

1 reference

5 August 2017

Eric B Haura

2

1 reference

5 August 2017

Barbara Roig

3

1 reference

5 August 2017

Miquel Taron

4

1 reference

5 August 2017

Albert Abad

5

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

3

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

763-780

1 reference

Chemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Determinants of response and resistance to cytotoxics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Translational oncogenomics: toward rational therapeutic decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Prediction of the response of colorectal cancer to systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Pemetrexed combination therapy in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Pharmacogenetics and folate metabolism -- a promising direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Pemetrexed disodium, a novel antifolate with multiple targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Understanding the cancer biology universe: enigmas, context and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Nitric oxide-mediated regulation of chemosensitivity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Predictive molecular markers in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Cell transformation by the viral src oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Activating SRC mutation in a subset of advanced human colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Increasing complexity of the Ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Phosphatidylinositol-3-OH kinase as a direct target of Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Activation of STAT transcription factors in oncogenic tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Stat3 activation is required for cellular transformation by v-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Stat3 activation by Src induces specific gene regulation and is required for cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

STAT3 is required for the gp130-mediated full activation of the c-myc gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Serum levels of interleukin 6 in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Growth factor modulation of p53-mediated growth arrest versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.6.763

21 January 2018

Identifiers

DOI

10.1517/14622416.3.6.763

1 reference

5 August 2017

1 reference